bg
X

Xencor (XNCR)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Xencor (XNCR)

Xencor, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing engineered monoclonal antibodies to treat severe and life threatening diseases. It has developed two clinical-stage product candidates, u... Read more

  • USD22.49
  • USD22.60
  • USD22.41
  • USD30.21
  • -15.50%
  • 168M
  • 3.65k
  • 748.41k
  • 1.4B
  • 16.49
  • -20.30%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.